News
Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.
Background: Previous guidelines recommend doubling the daily dose of maintenance inhaled corticosteroid to treat or prevent progression of exacerbations of asthma. Methods: Over a 6 month period a ...
We included randomised controlled trials testing the combination of LABA and ICS versus the same, or an increased, dose of ICS for at least four weeks in children and adolescents with asthma. The main ...
Long-acting muscarinic antagonists (LAMA), a class of drugs with proven effectiveness in chronic obstructive pulmonary disease (COPD), are being considered as an add-on option for adults with asthma ...
For highly symptomatic cases or with a severe exacerbation, low-dose maintenance and reliever therapy (MART) may be initiated, and stepping down to as-needed AIR therapy using a low-dose ...
The standard first-line treatment of acute asthma exacerbations includes oxygen, inhaled beta-agonist medications and systemic corticosteroids. 4 Additional medications are added to this first-line ...
Background It is well established that there are different asthma phenotypes, but whereas determinants of atopic asthma (AA) are well studied, little is known about non-atopic asthma (NAA). We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results